International Triadin Knockout Syndrome Registry: The Clinical Phenotype and Treatment Outcomes of Patients with Triadin Knockout Syndrome

Medicine and Dentistry

• Cardiac Dysrhythmia 33%
• Clinical Genetics 33%
• Defibrillator 33%
• Diseases 66%
• Faintness 33%
• Gene Therapy 66%
• Genetic Screening 33%
• Heart Arrest 100%
• Heart Ventricle Arrhythmia 33%
• Muscle Weakness 33%
• Myopathy 33%
• Precordial Lead 33%
• QT Prolongation 100%
• T Wave Inversion 100%
• Treatment Outcome 100%

Keyphrases

• Aggressive Treatment 10%
• Breakthrough Cardiac Events 10%
• Cardiac Arrest 20%
• Clinical Genetics 10%
• Clinical Phenotype 100%
• Clinical Treatment 100%
• Compound Heterozygous mutation 10%
• Conventional Therapy 10%
• Disease Expression 10%
• Early childhood 10%
• Exercise Stress Test 10%
• Exercise-induced 10%
• Gene Therapy 10%
• Gene Therapy Trials 10%
• Genetic Data 10%
• Genetic Testing 10%
• Implantable Defibrillator 10%
• Inherited Arrhythmia Syndrome 10%
• Lethal Infection 10%
• Null mutation 20%
• Online Survey 10%
• Precordial Leads 10%
• Proximal muscle Weakness 10%
• QT Prolongation 30%
• Research Electronic Data Capture (REDCap) 10%
• Severe Disease 10%
• Skeletal Myopathy 10%
• Syncope 10%
• T-wave Inversion 30%
• Treatment Outcome 100%
• Treatment Strategy 10%
• Triadin 20%
• Triadin KnockOut Syndrome 100%
• Unexplained Cardiac Arrest 10%
• Ventricular Arrhythmia 10%
• Ventricular Ectopy 10%
• Young Age 10%
• Young children 10%

Biochemistry, Genetics and Molecular Biology

• Cardiac Arrest 25%
• Cardiac Dysrhythmia 16%
• Gene Therapy 16%
• Genetic Screening 8%
• Genetics 8%
• T Wave Inversion 25%
• Triadin 100%